MAESTRO Study: Multisystem Profiling of Neurocognitive and Immune Responses to Lyme Disease and COVID-19

Project Coordinator
Michal Caspi Tal

The Tal Research Group is running a clinical study at MIT, MAESTRO comparing the response to Lyme disease and COVID with comprehensive neurocognitive assessments combined with metagenomic, proteomic, pathogen, and immune profiling to deeply investigate sex and age differences of immune responses to Lyme disease and how to identify those who are most at risk of not returning to health. At CCTR, data is collected from multiple organ systems, including brain activity, during structured tasks. The WAVi headset (pictured) is a brain imaging device that uses EEG technology to measure brain activity during cognitive tasks. It provides objective data on brain function, including processing speed, reaction time, and overall neurocognitive health.

EEG being completed for the MAESTRO study.